Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 1651 AL 1665

An autopsy case of MV2K-type sporadic Creutzfeldt-Jakob disease presenting with characteristic clinical, radiological, and neuropathological findings

Matsuo K, Goto D, Hasegawa M, Ogita K, Koyama T, Akagi A, Kitamoto T, Yoshida M, Iwasaki Y.

Neuropathology. 2022 Jun;42(3):245-253. doi: 10.1111/neup.12804. Epub 2022 Apr 19.

Ataxia-telangiectasia mutated (ATM) gene mutation in a patient with primary cutaneous marginal zone lymphoma

Sarver MM, Breglio KF, Olsen EA.

JAAD Case Rep. 2022 Mar 10;23:73-75. doi: 10.1016/j.jdcr.2022.02.032. eCollection 2022 May.

PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases

Kretzschmar D.

Metabolites. 2022 Mar 24;12(4):284. doi: 10.3390/metabo12040284.

A Case of Metastatic Basal Cell Carcinoma (BCC) With Spinal and Pulmonary Metastases Treated With Vismodegib, Sonedigib, and Radiotherapy

Samia AM, Nenow JM, Boyer P.

Cureus. 2022 Mar 17;14(3):e23273. doi: 10.7759/cureus.23273. eCollection 2022 Mar.

Autoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar Signs: A Case Report

Vinke AM, Zong S, Janssen JH, Correia-Hoffmann C, Mané-Damas M, Damoiseaux JGMC, de Vries JM, Pröpper D, Molenaar P, Losen M, Martinez Martinez P, Rouhl RPW.

Neurol Neuroimmunol Neuroinflamm. 2022 Apr 21;9(4):e1171. doi: 10.1212/NXI.0000000000001171. Print 2022 Jul.

Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis

Bhartiya M, Kumar A, Singh RK, Radhakrishnan DM, Rajan R, Srivastava AK.

Cerebellum. 2023 Jun;22(3):363-369. doi: 10.1007/s12311-022-01403-6. Epub 2022 Apr 22.

Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia

Subramanian GN, Yeo AJ, Gatei MH, Coman DJ, Lavin MF.

Antioxidants (Basel). 2022 Mar 28;11(4):653. doi: 10.3390/antiox11040653.

Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review

Altuna M, Ruiz I, Zelaya MV, Mendioroz M.

Medicina (Kaunas). 2022 Mar 25;58(4):473. doi: 10.3390/medicina58040473.

Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders

Pastorczak A, Attarbaschi A, Bomken S, Borkhardt A, van der Werff Ten Bosch J, Elitzur S, Gennery AR, Hlavackova E, Kerekes A, Křenová Z, Mlynarski W, Szczepanski T, Wassenberg T, Loeffen J.

Cancers (Basel). 2022 Apr 14;14(8):2000. doi: 10.3390/cancers14082000.

Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy

Matsumoto Y.

Int J Mol Sci. 2022 Apr 12;23(8):4264. doi: 10.3390/ijms23084264.

Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR)

Wang LW, Jiang S, Yuan YH, Duan J, Mao ND, Hui Z, Bai R, Xie T, Ye XY.

Molecules. 2022 Apr 12;27(8):2491. doi: 10.3390/molecules27082491.

Shivering and Stringhalt in horses

Valberg SJ, Baird JD.

Vet J. 2022 Apr;282:105829. doi: 10.1016/j.tvjl.2022.105829. Epub 2022 Apr 21.

Erdheim-Chester Disease Revealed by Central Positional Nystagmus: A Case Report

Weckel A, Gallois Y, Debs R, Escude B, Tremelet L, Varenne F, Biotti D, Chauveau D, Bonneville F.

Front Neurol. 2022 Apr 7;13:880312. doi: 10.3389/fneur.2022.880312. eCollection 2022.

Fahr's Disease With Late Onset: A Case Report

Iqbal S, Nassar M, Chung H, Shaukat T, Penny JE 2nd, Rizzo V.

Cureus. 2022 Mar 19;14(3):e23316. doi: 10.7759/cureus.23316. eCollection 2022 Mar.

Mitochondrial Ataxias: Molecular Classification and Clinical Heterogeneity

Lopriore P, Ricciarini V, Siciliano G, Mancuso M, Montano V.

Neurol Int. 2022 Apr 2;14(2):337-356. doi: 10.3390/neurolint14020028.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias